argenx SE
argenx SE ARGNF Peers
See (ARGNF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ARGNF | $562.00 | N/A | 34.3B | 34.25 | $16.41 | N/A |
| NONOF | $70.69 | +2.15% | 313.8B | 19.80 | $3.57 | +2.35% |
| CSLLY | $79.70 | +0.06% | 154.4B | 29.30 | $2.72 | +1.67% |
| CMXHF | $152.17 | -8.23% | 73.7B | 27.92 | $5.45 | +1.82% |
| BBIXF | $0.05 | +50900.00% | 44B | -5.10 | -$0.01 | N/A |
| UCBJY | $90.86 | +2.91% | 35.3B | 28.94 | $3.14 | +0.87% |
| UCBJF | $179.39 | +2.07% | 34.1B | 28.75 | $6.24 | +0.88% |
| ODTC | $22,005.00 | +29.44% | 24.1B | -0.08 | -$268,995.00 | N/A |
| WXIBF | $3.20 | +6.67% | 13B | 29.09 | $0.11 | N/A |
| IVBXF | $7.81 | -1.74% | 12.9B | -780.64 | -$0.01 | N/A |
Stock Comparison
ARGNF vs NONOF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, NONOF has a market cap of 313.8B. Regarding current trading prices, ARGNF is priced at $562.00, while NONOF trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas NONOF's P/E ratio is 19.80. In terms of profitability, ARGNF's ROE is +0.16%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, ARGNF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CSLLY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, CSLLY has a market cap of 154.4B. Regarding current trading prices, ARGNF is priced at $562.00, while CSLLY trades at $79.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas CSLLY's P/E ratio is 29.30. In terms of profitability, ARGNF's ROE is +0.16%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, ARGNF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CMXHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, CMXHF has a market cap of 73.7B. Regarding current trading prices, ARGNF is priced at $562.00, while CMXHF trades at $152.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas CMXHF's P/E ratio is 27.92. In terms of profitability, ARGNF's ROE is +0.16%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, ARGNF and CMXHF have similar daily volatility (0.00).
ARGNF vs BBIXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, BBIXF has a market cap of 44B. Regarding current trading prices, ARGNF is priced at $562.00, while BBIXF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas BBIXF's P/E ratio is -5.10. In terms of profitability, ARGNF's ROE is +0.16%, compared to BBIXF's ROE of -2.10%. Regarding short-term risk, ARGNF is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs UCBJY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, UCBJY has a market cap of 35.3B. Regarding current trading prices, ARGNF is priced at $562.00, while UCBJY trades at $90.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas UCBJY's P/E ratio is 28.94. In terms of profitability, ARGNF's ROE is +0.16%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, ARGNF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs UCBJF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, UCBJF has a market cap of 34.1B. Regarding current trading prices, ARGNF is priced at $562.00, while UCBJF trades at $179.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas UCBJF's P/E ratio is 28.75. In terms of profitability, ARGNF's ROE is +0.16%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, ARGNF and UCBJF have similar daily volatility (0.00).
ARGNF vs ODTC Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, ARGNF is priced at $562.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas ODTC's P/E ratio is -0.08. In terms of profitability, ARGNF's ROE is +0.16%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ARGNF and ODTC have similar daily volatility (0.00).
ARGNF vs WXIBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, WXIBF has a market cap of 13B. Regarding current trading prices, ARGNF is priced at $562.00, while WXIBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas WXIBF's P/E ratio is 29.09. In terms of profitability, ARGNF's ROE is +0.16%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, ARGNF and WXIBF have similar daily volatility (0.00).
ARGNF vs IVBXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, IVBXF has a market cap of 12.9B. Regarding current trading prices, ARGNF is priced at $562.00, while IVBXF trades at $7.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas IVBXF's P/E ratio is -780.64. In terms of profitability, ARGNF's ROE is +0.16%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, ARGNF and IVBXF have similar daily volatility (0.00).
ARGNF vs GNMSF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, GNMSF has a market cap of 12.8B. Regarding current trading prices, ARGNF is priced at $562.00, while GNMSF trades at $207.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas GNMSF's P/E ratio is 12.20. In terms of profitability, ARGNF's ROE is +0.16%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, ARGNF is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs WXXWY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, WXXWY has a market cap of 12.8B. Regarding current trading prices, ARGNF is priced at $562.00, while WXXWY trades at $6.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas WXXWY's P/E ratio is 26.16. In terms of profitability, ARGNF's ROE is +0.16%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, ARGNF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SBMFF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, SBMFF has a market cap of 10B. Regarding current trading prices, ARGNF is priced at $562.00, while SBMFF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas SBMFF's P/E ratio is 56.11. In terms of profitability, ARGNF's ROE is +0.16%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, ARGNF and SBMFF have similar daily volatility (0.00).
ARGNF vs SBHMY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, SBHMY has a market cap of 8.7B. Regarding current trading prices, ARGNF is priced at $562.00, while SBHMY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas SBHMY's P/E ratio is 33.62. In terms of profitability, ARGNF's ROE is +0.16%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, ARGNF and SBHMY have similar daily volatility (0.00).
ARGNF vs TRSBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, TRSBF has a market cap of 6.1B. Regarding current trading prices, ARGNF is priced at $562.00, while TRSBF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas TRSBF's P/E ratio is 21.67. In terms of profitability, ARGNF's ROE is +0.16%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, ARGNF and TRSBF have similar daily volatility (0.00).
ARGNF vs TLPPF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, TLPPF has a market cap of 5.4B. Regarding current trading prices, ARGNF is priced at $562.00, while TLPPF trades at $16.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas TLPPF's P/E ratio is 178.07. In terms of profitability, ARGNF's ROE is +0.16%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, ARGNF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ABCZF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, ARGNF is priced at $562.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, ARGNF and ABCZF have similar daily volatility (0.00).
ARGNF vs ZLDPF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, ZLDPF has a market cap of 5B. Regarding current trading prices, ARGNF is priced at $562.00, while ZLDPF trades at $70.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas ZLDPF's P/E ratio is -26.69. In terms of profitability, ARGNF's ROE is +0.16%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, ARGNF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs INCPF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, ARGNF is priced at $562.00, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas INCPF's P/E ratio is -108.67. In terms of profitability, ARGNF's ROE is +0.16%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, ARGNF and INCPF have similar daily volatility (0.00).
ARGNF vs AKBLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, AKBLF has a market cap of 4.8B. Regarding current trading prices, ARGNF is priced at $562.00, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas AKBLF's P/E ratio is 33.36. In terms of profitability, ARGNF's ROE is +0.16%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, ARGNF is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs LABFF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, ARGNF is priced at $562.00, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ARGNF's ROE is +0.16%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, ARGNF and LABFF have similar daily volatility (0.00).
ARGNF vs REGMF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, REGMF has a market cap of 3.4B. Regarding current trading prices, ARGNF is priced at $562.00, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas REGMF's P/E ratio is -13.32. In terms of profitability, ARGNF's ROE is +0.16%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, ARGNF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs GLPGF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, GLPGF has a market cap of 3.2B. Regarding current trading prices, ARGNF is priced at $562.00, while GLPGF trades at $48.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas GLPGF's P/E ratio is -15.66. In terms of profitability, ARGNF's ROE is +0.16%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, ARGNF is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CAMRF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, CAMRF has a market cap of 3.1B. Regarding current trading prices, ARGNF is priced at $562.00, while CAMRF trades at $52.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas CAMRF's P/E ratio is 54.49. In terms of profitability, ARGNF's ROE is +0.16%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, ARGNF and CAMRF have similar daily volatility (0.00).
ARGNF vs TKBIF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, ARGNF is priced at $562.00, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, ARGNF's ROE is +0.16%, compared to TKBIF's ROE of N/A. Regarding short-term risk, ARGNF and TKBIF have similar daily volatility (0.00).
ARGNF vs GNNSF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, GNNSF has a market cap of 2.8B. Regarding current trading prices, ARGNF is priced at $562.00, while GNNSF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas GNNSF's P/E ratio is -16.25. In terms of profitability, ARGNF's ROE is +0.16%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, ARGNF and GNNSF have similar daily volatility (0.00).
ARGNF vs MPSYF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, ARGNF is priced at $562.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ARGNF's ROE is +0.16%, compared to MPSYF's ROE of +2.51%. Regarding short-term risk, ARGNF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ASPHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, ASPHF has a market cap of 2.2B. Regarding current trading prices, ARGNF is priced at $562.00, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, ARGNF's ROE is +0.16%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, ARGNF and ASPHF have similar daily volatility (0.00).
ARGNF vs SHJBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, SHJBF has a market cap of 2.1B. Regarding current trading prices, ARGNF is priced at $562.00, while SHJBF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas SHJBF's P/E ratio is -7.22. In terms of profitability, ARGNF's ROE is +0.16%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, ARGNF and SHJBF have similar daily volatility (0.00).
ARGNF vs BVNKF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, BVNKF has a market cap of 2B. Regarding current trading prices, ARGNF is priced at $562.00, while BVNKF trades at $26.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas BVNKF's P/E ratio is 10.44. In terms of profitability, ARGNF's ROE is +0.16%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, ARGNF and BVNKF have similar daily volatility (0.00).
ARGNF vs BVNRY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, BVNRY has a market cap of 2B. Regarding current trading prices, ARGNF is priced at $562.00, while BVNRY trades at $8.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas BVNRY's P/E ratio is 10.06. In terms of profitability, ARGNF's ROE is +0.16%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, ARGNF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SYGGF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, SYGGF has a market cap of 2B. Regarding current trading prices, ARGNF is priced at $562.00, while SYGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas SYGGF's P/E ratio is -0.47. In terms of profitability, ARGNF's ROE is +0.16%, compared to SYGGF's ROE of -0.62%. Regarding short-term risk, ARGNF and SYGGF have similar daily volatility (0.00).
ARGNF vs BTTAY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, ARGNF is priced at $562.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, ARGNF's ROE is +0.16%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, ARGNF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs MEOBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, MEOBF has a market cap of 1.8B. Regarding current trading prices, ARGNF is priced at $562.00, while MEOBF trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas MEOBF's P/E ratio is -16.05. In terms of profitability, ARGNF's ROE is +0.16%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, ARGNF and MEOBF have similar daily volatility (0.00).
ARGNF vs GENSF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, ARGNF is priced at $562.00, while GENSF trades at $26.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas GENSF's P/E ratio is -332.47. In terms of profitability, ARGNF's ROE is +0.16%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, ARGNF and GENSF have similar daily volatility (0.00).
ARGNF vs BRCTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, ARGNF is priced at $562.00, while BRCTF trades at $18.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas BRCTF's P/E ratio is 17.68. In terms of profitability, ARGNF's ROE is +0.16%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, ARGNF and BRCTF have similar daily volatility (0.00).
ARGNF vs PHMMF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, ARGNF is priced at $562.00, while PHMMF trades at $93.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas PHMMF's P/E ratio is 72.57. In terms of profitability, ARGNF's ROE is +0.16%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, ARGNF and PHMMF have similar daily volatility (0.00).
ARGNF vs BIESF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, ARGNF is priced at $562.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas BIESF's P/E ratio is -44.44. In terms of profitability, ARGNF's ROE is +0.16%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, ARGNF and BIESF have similar daily volatility (0.00).
ARGNF vs ONTTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, ARGNF is priced at $562.00, while ONTTF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas ONTTF's P/E ratio is -7.65. In terms of profitability, ARGNF's ROE is +0.16%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, ARGNF and ONTTF have similar daily volatility (0.00).
ARGNF vs PPTDF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, PPTDF has a market cap of 1.5B. Regarding current trading prices, ARGNF is priced at $562.00, while PPTDF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas PPTDF's P/E ratio is 15.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, ARGNF is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CSBTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, CSBTF has a market cap of 1.2B. Regarding current trading prices, ARGNF is priced at $562.00, while CSBTF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas CSBTF's P/E ratio is -266.67. In terms of profitability, ARGNF's ROE is +0.16%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, ARGNF is less volatile compared to CSBTF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs NURPF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, ARGNF is priced at $562.00, while NURPF trades at $8.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas NURPF's P/E ratio is 11.67. In terms of profitability, ARGNF's ROE is +0.16%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, ARGNF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SNBIF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, SNBIF has a market cap of 926.4M. Regarding current trading prices, ARGNF is priced at $562.00, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, ARGNF's ROE is +0.16%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, ARGNF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ASCLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, ASCLF has a market cap of 904M. Regarding current trading prices, ARGNF is priced at $562.00, while ASCLF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas ASCLF's P/E ratio is -23.31. In terms of profitability, ARGNF's ROE is +0.16%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, ARGNF and ASCLF have similar daily volatility (0.00).
ARGNF vs PHGUF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, PHGUF has a market cap of 680.3M. Regarding current trading prices, ARGNF is priced at $562.00, while PHGUF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, ARGNF and PHGUF have similar daily volatility (0.00).
ARGNF vs BPMUF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, BPMUF has a market cap of 636.6M. Regarding current trading prices, ARGNF is priced at $562.00, while BPMUF trades at $51.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas BPMUF's P/E ratio is 7.30. In terms of profitability, ARGNF's ROE is +0.16%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, ARGNF is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs INRLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, INRLF has a market cap of 552.7M. Regarding current trading prices, ARGNF is priced at $562.00, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas INRLF's P/E ratio is -5.08. In terms of profitability, ARGNF's ROE is +0.16%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, ARGNF and INRLF have similar daily volatility (0.00).
ARGNF vs SOLTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, SOLTF has a market cap of 534.2M. Regarding current trading prices, ARGNF is priced at $562.00, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas SOLTF's P/E ratio is -32.83. In terms of profitability, ARGNF's ROE is +0.16%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, ARGNF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs IVEVF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, IVEVF has a market cap of 505.9M. Regarding current trading prices, ARGNF is priced at $562.00, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, ARGNF's ROE is +0.16%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, ARGNF and IVEVF have similar daily volatility (0.00).
ARGNF vs CLTEF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, CLTEF has a market cap of 504.7M. Regarding current trading prices, ARGNF is priced at $562.00, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, ARGNF's ROE is +0.16%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, ARGNF and CLTEF have similar daily volatility (0.00).
ARGNF vs BXPHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, BXPHF has a market cap of 489.2M. Regarding current trading prices, ARGNF is priced at $562.00, while BXPHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas BXPHF's P/E ratio is -24.95. In terms of profitability, ARGNF's ROE is +0.16%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, ARGNF is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CKDXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, CKDXF has a market cap of 475.3M. Regarding current trading prices, ARGNF is priced at $562.00, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ARGNF's ROE is +0.16%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, ARGNF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs VBIZF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, VBIZF has a market cap of 473M. Regarding current trading prices, ARGNF is priced at $562.00, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, ARGNF's ROE is +0.16%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, ARGNF and VBIZF have similar daily volatility (0.00).
ARGNF vs MDCLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, MDCLF has a market cap of 463M. Regarding current trading prices, ARGNF is priced at $562.00, while MDCLF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas MDCLF's P/E ratio is -10.45. In terms of profitability, ARGNF's ROE is +0.16%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, ARGNF is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs AAVXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, AAVXF has a market cap of 457.4M. Regarding current trading prices, ARGNF is priced at $562.00, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas AAVXF's P/E ratio is -2.26. In terms of profitability, ARGNF's ROE is +0.16%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, ARGNF and AAVXF have similar daily volatility (0.00).
ARGNF vs RAONF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, ARGNF is priced at $562.00, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas RAONF's P/E ratio is -43.33. In terms of profitability, ARGNF's ROE is +0.16%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, ARGNF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BOVNF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, ARGNF is priced at $562.00, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas BOVNF's P/E ratio is -12.05. In terms of profitability, ARGNF's ROE is +0.16%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, ARGNF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CSPHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, CSPHF has a market cap of 435.6M. Regarding current trading prices, ARGNF is priced at $562.00, while CSPHF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas CSPHF's P/E ratio is -32.10. In terms of profitability, ARGNF's ROE is +0.16%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, ARGNF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs TBGNF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, ARGNF is priced at $562.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ARGNF's ROE is +0.16%, compared to TBGNF's ROE of N/A. Regarding short-term risk, ARGNF and TBGNF have similar daily volatility (0.00).
ARGNF vs CYDY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, CYDY has a market cap of 418.8M. Regarding current trading prices, ARGNF is priced at $562.00, while CYDY trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas CYDY's P/E ratio is -16.99. In terms of profitability, ARGNF's ROE is +0.16%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, ARGNF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs HBMHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, HBMHF has a market cap of 407.9M. Regarding current trading prices, ARGNF is priced at $562.00, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, ARGNF's ROE is +0.16%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, ARGNF and HBMHF have similar daily volatility (0.00).
ARGNF vs GSGTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, GSGTF has a market cap of 403.2M. Regarding current trading prices, ARGNF is priced at $562.00, while GSGTF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas GSGTF's P/E ratio is -8.16. In terms of profitability, ARGNF's ROE is +0.16%, compared to GSGTF's ROE of +0.78%. Regarding short-term risk, ARGNF is less volatile compared to GSGTF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PTCHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, PTCHF has a market cap of 396.3M. Regarding current trading prices, ARGNF is priced at $562.00, while PTCHF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas PTCHF's P/E ratio is 7.86. In terms of profitability, ARGNF's ROE is +0.16%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, ARGNF and PTCHF have similar daily volatility (0.00).
ARGNF vs NWBO Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, NWBO has a market cap of 392.6M. Regarding current trading prices, ARGNF is priced at $562.00, while NWBO trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas NWBO's P/E ratio is -4.54. In terms of profitability, ARGNF's ROE is +0.16%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, ARGNF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CLVLY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, CLVLY has a market cap of 357.9M. Regarding current trading prices, ARGNF is priced at $562.00, while CLVLY trades at $7.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas CLVLY's P/E ratio is 14.28. In terms of profitability, ARGNF's ROE is +0.16%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, ARGNF is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CLVLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, CLVLF has a market cap of 348.4M. Regarding current trading prices, ARGNF is priced at $562.00, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas CLVLF's P/E ratio is 13.90. In terms of profitability, ARGNF's ROE is +0.16%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, ARGNF and CLVLF have similar daily volatility (0.00).
ARGNF vs HLOSF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, HLOSF has a market cap of 321.6M. Regarding current trading prices, ARGNF is priced at $562.00, while HLOSF trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas HLOSF's P/E ratio is -9.91. In terms of profitability, ARGNF's ROE is +0.16%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, ARGNF is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs IDRSF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, IDRSF has a market cap of 305.7M. Regarding current trading prices, ARGNF is priced at $562.00, while IDRSF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas IDRSF's P/E ratio is -0.91. In terms of profitability, ARGNF's ROE is +0.16%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, ARGNF and IDRSF have similar daily volatility (0.00).
ARGNF vs PBBIF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, ARGNF is priced at $562.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ARGNF's ROE is +0.16%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ARGNF is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PRRUF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, PRRUF has a market cap of 283.3M. Regarding current trading prices, ARGNF is priced at $562.00, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas PRRUF's P/E ratio is -9.70. In terms of profitability, ARGNF's ROE is +0.16%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, ARGNF and PRRUF have similar daily volatility (0.00).
ARGNF vs NGENF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, NGENF has a market cap of 281.8M. Regarding current trading prices, ARGNF is priced at $562.00, while NGENF trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas NGENF's P/E ratio is -13.89. In terms of profitability, ARGNF's ROE is +0.16%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, ARGNF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs GNFTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, GNFTF has a market cap of 276.3M. Regarding current trading prices, ARGNF is priced at $562.00, while GNFTF trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas GNFTF's P/E ratio is 13.87. In terms of profitability, ARGNF's ROE is +0.16%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, ARGNF and GNFTF have similar daily volatility (0.00).
ARGNF vs IPHYF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, IPHYF has a market cap of 267.3M. Regarding current trading prices, ARGNF is priced at $562.00, while IPHYF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas IPHYF's P/E ratio is -4.20. In terms of profitability, ARGNF's ROE is +0.16%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, ARGNF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs TRGNF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, TRGNF has a market cap of 263.9M. Regarding current trading prices, ARGNF is priced at $562.00, while TRGNF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas TRGNF's P/E ratio is -6.06. In terms of profitability, ARGNF's ROE is +0.16%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, ARGNF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs OPORF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, OPORF has a market cap of 240.5M. Regarding current trading prices, ARGNF is priced at $562.00, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas OPORF's P/E ratio is 17.50. In terms of profitability, ARGNF's ROE is +0.16%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, ARGNF and OPORF have similar daily volatility (0.00).
ARGNF vs AVCTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, AVCTF has a market cap of 239M. Regarding current trading prices, ARGNF is priced at $562.00, while AVCTF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas AVCTF's P/E ratio is -5.19. In terms of profitability, ARGNF's ROE is +0.16%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, ARGNF and AVCTF have similar daily volatility (0.00).
ARGNF vs ORYZF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, ARGNF is priced at $562.00, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, ARGNF's ROE is +0.16%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, ARGNF and ORYZF have similar daily volatility (0.00).
ARGNF vs NWPHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, ARGNF is priced at $562.00, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ARGNF's ROE is +0.16%, compared to NWPHF's ROE of N/A. Regarding short-term risk, ARGNF and NWPHF have similar daily volatility (0.00).
ARGNF vs SLNCF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, SLNCF has a market cap of 225.3M. Regarding current trading prices, ARGNF is priced at $562.00, while SLNCF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas SLNCF's P/E ratio is -3.12. In terms of profitability, ARGNF's ROE is +0.16%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, ARGNF and SLNCF have similar daily volatility (0.00).
ARGNF vs HNSBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, HNSBF has a market cap of 223.8M. Regarding current trading prices, ARGNF is priced at $562.00, while HNSBF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas HNSBF's P/E ratio is -2.58. In terms of profitability, ARGNF's ROE is +0.16%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, ARGNF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SPHDF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, SPHDF has a market cap of 211.7M. Regarding current trading prices, ARGNF is priced at $562.00, while SPHDF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas SPHDF's P/E ratio is -3.66. In terms of profitability, ARGNF's ROE is +0.16%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, ARGNF is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs FPHAF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, ARGNF is priced at $562.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ARGNF's ROE is +0.16%, compared to FPHAF's ROE of N/A. Regarding short-term risk, ARGNF and FPHAF have similar daily volatility (0.00).
ARGNF vs VSBC Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, ARGNF is priced at $562.00, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas VSBC's P/E ratio is N/A. In terms of profitability, ARGNF's ROE is +0.16%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, ARGNF and VSBC have similar daily volatility (0.00).
ARGNF vs FGHQF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, ARGNF is priced at $562.00, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, ARGNF's ROE is +0.16%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, ARGNF is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs AMGXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, AMGXF has a market cap of 190.7M. Regarding current trading prices, ARGNF is priced at $562.00, while AMGXF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas AMGXF's P/E ratio is -0.69. In terms of profitability, ARGNF's ROE is +0.16%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, ARGNF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CMVLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, CMVLF has a market cap of 187.4M. Regarding current trading prices, ARGNF is priced at $562.00, while CMVLF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas CMVLF's P/E ratio is -3.88. In terms of profitability, ARGNF's ROE is +0.16%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, ARGNF is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BSEM Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, BSEM has a market cap of 182.2M. Regarding current trading prices, ARGNF is priced at $562.00, while BSEM trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas BSEM's P/E ratio is -19.56. In terms of profitability, ARGNF's ROE is +0.16%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, ARGNF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SCNLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, SCNLF has a market cap of 176M. Regarding current trading prices, ARGNF is priced at $562.00, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, ARGNF's ROE is +0.16%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, ARGNF and SCNLF have similar daily volatility (0.00).
ARGNF vs RECEF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, RECEF has a market cap of 157.2M. Regarding current trading prices, ARGNF is priced at $562.00, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas RECEF's P/E ratio is -10.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, ARGNF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs MLLCF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, ARGNF is priced at $562.00, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas MLLCF's P/E ratio is -2.04. In terms of profitability, ARGNF's ROE is +0.16%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, ARGNF is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PBIGF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, PBIGF has a market cap of 140.2M. Regarding current trading prices, ARGNF is priced at $562.00, while PBIGF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas PBIGF's P/E ratio is -12.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, ARGNF and PBIGF have similar daily volatility (0.00).
ARGNF vs BRIBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, BRIBF has a market cap of 134.1M. Regarding current trading prices, ARGNF is priced at $562.00, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, ARGNF's ROE is +0.16%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, ARGNF and BRIBF have similar daily volatility (0.00).
ARGNF vs HOFBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, HOFBF has a market cap of 130.4M. Regarding current trading prices, ARGNF is priced at $562.00, while HOFBF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas HOFBF's P/E ratio is -11.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to HOFBF's ROE of -1.07%. Regarding short-term risk, ARGNF is less volatile compared to HOFBF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs AAPGV Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, ARGNF is priced at $562.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ARGNF's ROE is +0.16%, compared to AAPGV's ROE of N/A. Regarding short-term risk, ARGNF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PRNAF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, PRNAF has a market cap of 126.9M. Regarding current trading prices, ARGNF is priced at $562.00, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, ARGNF's ROE is +0.16%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, ARGNF and PRNAF have similar daily volatility (0.00).
ARGNF vs PSTTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, ARGNF is priced at $562.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to PSTTF's ROE of N/A. Regarding short-term risk, ARGNF and PSTTF have similar daily volatility (0.00).
ARGNF vs EPRXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, ARGNF is priced at $562.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ARGNF's ROE is +0.16%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, ARGNF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs MMIRF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, MMIRF has a market cap of 106.3M. Regarding current trading prices, ARGNF is priced at $562.00, while MMIRF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas MMIRF's P/E ratio is -7.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to MMIRF's ROE of +0.24%. Regarding short-term risk, ARGNF and MMIRF have similar daily volatility (0.00).
ARGNF vs IUGNF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, IUGNF has a market cap of 104.5M. Regarding current trading prices, ARGNF is priced at $562.00, while IUGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas IUGNF's P/E ratio is -1.40. In terms of profitability, ARGNF's ROE is +0.16%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, ARGNF and IUGNF have similar daily volatility (0.00).
ARGNF vs ADOIF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 34.3B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, ARGNF is priced at $562.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 34.25, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, ARGNF's ROE is +0.16%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, ARGNF and ADOIF have similar daily volatility (0.00).